Oxford University Press, Clinical Infectious Diseases, 8(71), p. e215-e217, 2020
DOI: 10.1093/cid/ciaa145
Full text: Download
Abstract The transmission of direct-acting antiviral resistance-associated substitutions (RAS) could hamper hepatitis C virus (HCV) cure rates and elimination efforts. A phylogenetic analysis of 87 men who have sex with men recently infected with HCV genotype 1a placed one-third (28/87) in a large cluster, in which 96% harbored NS5A M28V RAS.